# DMRA (Damora Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Damora Therapeutics, Inc. reported $532.6M in total assets and a net loss of $291.7M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/DMRA
- Markdown: https://convexityos.com/fundamentals/DMRA.md
- SEC CIK: 0001800315
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:26 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001800315&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$304.4M | Operating profit |
| Net Income | FY 2025 | -$291.7M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$4.72 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $528.5M | Total debt: $1.10M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $26.88M | $6.40M | $23.77M | $48.21M | $38.49M | $24.63M | $19.74M |
| Total Operating Expenses | $210.9M | $22.26M | $39.91M | $61.21M | $52.23M | $33.64M | $38.97M |
| **Operating Income** | -$210.9M | -$22.26M | -$39.91M | -$61.21M | -$52.23M | -$33.64M | $38.97M |
| **EBITDA** | -$210.8M | -$22.24M | -$39.64M | -$61.16M | -$52.21M | -- | -- |
| Income Before Tax | -$209.8M | -$21.40M | -$38.35M | -$61.62M | -$51.75M | -$34.84M | -$36.51M |
| Income Tax Expense | $50K | $41K | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$209.8M | -$21.44M | -$38.35M | -$61.62M | -$51.75M | -$34.84M | -$36.51M |
| Basic EPS | $3.98 | -$18.53 | -$36.08 | -$60.75 | -$51.25 | -$190.50 | -$4,045.50 |
| **Diluted EPS** | $3.98 | -$18.53 | -$36.08 | -$60.75 | -$51.25 | -$190.50 | -$4,045.50 |
| Basic Shares Outstanding | 1.4M | 1.2M | 1.1M | 1.0M | 1.0M | 182.9K | 10.4K |
| Diluted Shares Outstanding | 1.4M | 1.2M | 1.1M | 1.0M | 1.0M | 182.9K | 10.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $25.48M | $25.54M | $23.78M | $23.32M | $1.42M | $1.47M | $678K | $1.01M |
| Total Operating Expenses | $36.86M | $34.99M | $30.81M | $201.7M | $3.16M | $3.42M | $2.60M | $7.10M |
| **Operating Income** | -$36.86M | -$34.99M | -$30.81M | -$201.7M | -$3.16M | -$3.42M | -$2.60M | -$7.10M |
| **EBITDA** | -$36.86M | -$34.99M | -$30.81M | -$201.7M | -$3.15M | -$3.42M | -$2.59M | -$7.10M |
| Income Before Tax | -$31.99M | -$30.92M | -$27.74M | -$200.7M | -$3.13M | -$3.43M | -$2.53M | -$6.75M |
| Income Tax Expense | $0 | $255K | $42K | $44K | $0 | $4.0K | $2.0K | -- |
| **Net Income** | -$31.99M | -$31.17M | -$27.78M | -$200.7M | -$3.13M | -$3.44M | -$2.53M | -$6.74M |
| Basic EPS | -$0.40 | -$0.39 | -$0.62 | -- | -$2.36 | -$2.60 | -$1.92 | -- |
| **Diluted EPS** | -$0.40 | -$0.39 | -$0.62 | -- | -$2.36 | -$2.60 | -$1.92 | -- |
| Basic Shares Outstanding | 61.8M | 61.1M | 34.3M | -- | 1.3M | 1.3M | 1.3M | -- |
| Diluted Shares Outstanding | 61.8M | 61.1M | 34.3M | -- | 1.3M | 1.3M | 1.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $257.6M | $14.18M | $21.46M | $32.79M | $62.56M | $163.6M | $11.29M |
| Short-Term Investments | $0 | -- | $11.69M | $27.44M | $37.63M | -- | -- |
| **Cash & Short-Term Investments** | $257.6M | $14.18M | $33.15M | $60.22M | $100.2M | $163.6M | $11.29M |
| **Total Current Assets** | $260.4M | $16.84M | $36.77M | $63.91M | $110.1M | $169.3M | $56.08M |
| Property, Plant & Equipment, Net | $36K | $57K | $78K | $357K | $203K | -- | -- |
| Long-Term Investments | -- | -- | -- | $5.83M | $9.05M | -- | -- |
| Other Non-Current Assets | $36K | $163K | $1.13M | $2.28M | $2.03M | $1.16M | -- |
| **Total Non-Current Assets** | $104K | $293K | $1.45M | $9.28M | $12.11M | $2.30M | $529K |
| **Total Assets** | $260.5M | $17.13M | $38.23M | $73.19M | $122.2M | $171.6M | $56.61M |
| Accounts Payable | $444K | $377K | $1.70M | $3.35M | $1.53M | $2.85M | $3.33M |
| **Total Current Liabilities** | $20.07M | $1.20M | $5.83M | $11.11M | $4.54M | $5.57M | $7.93M |
| Other Non-Current Liabilities | $28K | $43K | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $81K | $104K | $66K | $328K | $448K | $541K | $211K |
| **Total Liabilities** | $20.15M | $1.30M | $5.90M | $11.44M | $4.99M | $6.11M | $8.14M |
| **Total Debt (incl. Leases)** | $68K | $73K | $249K | $804K | $846K | $915K | $298K |
| Retained Earnings | -$487.4M | -$277.5M | -$256.1M | -$217.7M | -$156.1M | -$104.4M | -$69.52M |
| Accumulated Other Comp. Income | $802K | $97K | $380K | -$244K | -$320K | $674K | -$2.45M |
| **Total Stockholders' Equity** | $239.0M | $14.47M | $32.33M | $61.75M | $117.2M | $165.5M | -$71.15M |
| Total Equity | $239.0M | $14.47M | $32.33M | $61.75M | $117.2M | $165.5M | -$71.15M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $349.7M | $540.5M | $532.9M | $257.6M | $7.61M | $10.21M | $11.94M | $14.18M |
| Short-Term Investments | $178.8M | -- | -- | $0 | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $528.5M | $540.5M | $532.9M | $257.6M | $7.61M | $10.21M | $11.94M | $14.18M |
| **Total Current Assets** | $531.3M | $543.6M | $535.4M | $260.4M | $9.79M | $13.03M | $14.92M | $16.84M |
| Property, Plant & Equipment, Net | -- | -- | -- | $36K | $41K | $47K | $52K | $57K |
| Other Non-Current Assets | $480K | $48K | $34K | $36K | $837K | $542K | $317K | $163K |
| **Total Non-Current Assets** | $1.31M | $48K | $34K | $104K | $950K | $664K | $442K | $293K |
| **Total Assets** | $532.6M | $543.6M | $535.4M | $260.5M | $10.74M | $13.69M | $15.37M | $17.13M |
| Accounts Payable | $6.08M | $3.48M | $819K | $444K | $520K | $756K | $354K | $377K |
| **Total Current Liabilities** | $35.89M | $27.55M | $23.81M | $20.07M | $2.62M | $2.63M | $1.55M | $1.20M |
| Other Non-Current Liabilities | $28K | $27K | $27K | $28K | $49K | $49K | $45K | $43K |
| **Total Non-Current Liabilities** | $974K | $27K | $27K | $81K | $106K | $109K | $105K | $104K |
| **Total Liabilities** | $36.87M | $27.58M | $23.84M | $20.15M | $2.73M | $2.74M | $1.66M | $1.30M |
| **Total Debt (incl. Leases)** | $1.10M | -- | -- | $68K | $72K | $75K | $73K | $73K |
| Common Stock | $1.0K | $1.0K | $1.0K | -- | -- | -- | -- | -- |
| Retained Earnings | -$578.3M | -$546.3M | -$515.1M | -$487.4M | -$286.6M | -$283.5M | -$280.1M | -$277.5M |
| Accumulated Other Comp. Income | -$233K | $732K | $754K | $802K | $823K | $809K | $300K | $97K |
| **Total Stockholders' Equity** | $495.8M | $516.1M | $511.6M | $239.0M | $6.67M | $9.61M | $13.71M | $14.47M |
| Total Equity | $495.8M | $516.1M | $511.6M | $239.0M | $6.67M | $9.61M | $13.71M | $14.47M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$209.8M | -$21.44M | -$38.35M | -$61.62M | -$51.75M | -$34.84M | -$36.51M |
| Depreciation & Amortization | $22K | $21K | $269K | $42K | $20K | -- | -- |
| Stock-Based Compensation | $998K | $3.24M | $5.43M | $5.57M | $4.48M | $982K | -- |
| Change in Payables | $51K | -$1.32M | -$1.65M | $1.82M | -$1.32M | -$477K | $1.94M |
| **Operating Cash Flow** | -$6.73M | -$18.62M | -$36.91M | -$42.93M | -$52.31M | -$38.20M | -$19.33M |
| Capital Expenditure | -- | -- | -- | -$196K | -$223K | -- | -- |
| **Free Cash Flow** | -- | -- | -- | -$43.13M | -$52.53M | -- | -- |
| Acquisitions, Net | -$17.37M | -- | -- | -- | -- | -- | -$326K |
| Purchases of Investments | -- | -- | -$25.94M | -$44.87M | -$84.21M | -- | -- |
| **Investing Cash Flow** | -$17.37M | $11.65M | $22.33M | $12.38M | -$48.05M | -- | -$326K |
| Common Stock Issued | -- | -- | $2.88M | $507K | -- | -- | -- |
| **Financing Cash Flow** | $266.8M | -- | $2.88M | $507K | -- | $187.4M | -- |
| **Net Change in Cash** | $242.7M | -$6.97M | -$11.71M | -$30.04M | -$100.4M | $149.2M | -$19.65M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$32.00M | -$31.20M | -$27.78M | -$200.7M | -$3.10M | -$3.40M | -$2.53M | -$6.74M |
| Depreciation & Amortization | $5.0K | $6.0K | $5.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K |
| Stock-Based Compensation | $7.54M | $6.14M | $3.13M | $483K | $164K | $172K | $179K | $308K |
| Change in Payables | $2.60M | $2.66M | $375K | -$92K | -$236K | $402K | -$23K | -$126K |
| **Operating Cash Flow** | -$17.23M | -$21.87M | -$20.60M | $566K | -$2.62M | -$2.24M | -$2.44M | -$4.94M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $5.12M | $29.50M | $295.9M | -- | -- | -- | -- | -- |
| **Net Change in Cash** | -$190.9M | $7.64M | $275.3M | $250.0M | -$2.62M | -$2.24M | -$2.44M | -$4.94M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -87.8% | -148.2% | -118.6% | -99.8% | -44.1% | -21.1% | -- |
| Return on Assets (ROA) | -80.5% | -125.1% | -100.3% | -84.2% | -42.3% | -20.3% | -64.5% |
| Current Ratio | 12.98x | 14.07x | 6.31x | 5.75x | 24.23x | 30.42x | 7.07x |
| Quick Ratio | 12.84x | 11.84x | 5.69x | 5.42x | 22.05x | 29.39x | 1.42x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -186.3% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -58.8% | -50.9% | -46.0% | -87.8% | -237.7% | -172.6% | -134.9% | -148.2% |
| Return on Assets (ROA) | -54.8% | -48.3% | -43.9% | -80.5% | -147.6% | -121.2% | -120.4% | -125.1% |
| Current Ratio | 14.80x | 19.73x | 22.48x | 12.98x | 3.73x | 4.96x | 9.62x | 14.07x |
| Quick Ratio | 14.72x | 19.62x | 22.38x | 12.84x | 2.90x | 3.88x | 7.70x | 11.84x |
| Debt to Equity | 0.00x | -- | -- | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
